Afamelanotide is a synthetic peptide analogue of alpha-melanocyte-stimulating hormone (α-MSH) used primarily to prevent phototoxicity in patients with erythropoietic protoporphyria by inducing melanin… Read more
Afamelanotide is a synthetic peptide analogue of alpha-melanocyte-stimulating hormone (α-MSH) used primarily to prevent phototoxicity in patients with erythropoietic protoporphyria by inducing melanin production for photoprotection against ultraviolet radiation. Pharmaceutical laboratories utilize high-quality reference standards of this compound to support critical stages of drug development and manufacturing. These materials are essential for impurity profiling, ensuring that synthesis byproducts and degradation products are accurately identified and quantified to meet stringent regulatory requirements. Additionally, stable isotope labelled versions of the drug serve as vital internal standards in mass spectrometry and bioanalytical method validation, allowing for precise quantification of the active ingredient and its metabolites in complex biological matrices. By maintaining consistency and reliability in analytical procedures, these reference standards provide the necessary benchmarks to confirm the purity and potency of the drug substance throughout its analytical lifecycle.